A patient with type 2 diabetes presents with persistent fatigue, blurred vision, and peripheral neuropathy. His blood pressure is 155/98 mmHg, and his HbA1c is 8.5%. Which intervention should the nurse prioritize to address his immediate risk factors and prevent further complications?

B) Initiate antihypertensive therapy to reduce blood pressure levels.

A) Increase the dosage of metformin to improve glycemic control.

B) Initiate antihypertensive therapy to reduce blood pressure levels.

C) Refer the patient to a diabetes educator for lifestyle modification counseling.

D) Schedule an urgent appointment with a podiatrist for foot care.

A patient with type 2 diabetes mellitus presents with persistent fatigue, worsening blurred vision, dizziness, and tingling in the feet. His blood pressure is 155/98 mmHg, and HbA1c is 8.5%. Considering these findings, what would be the most appropriate initial nursing action to address his condition?

C) Discuss dietary modifications and encourage increased physical activity to aid in weight management.

A) Educate the patient on the importance of daily foot exams to prevent diabetic foot ulcers.

B) Reinforce the importance of adhering to the prescribed metformin regimen to improve glycemic control.

C) Discuss dietary modifications and encourage increased physical activity to aid in weight management.

D) Instruct the patient to monitor blood pressure twice daily and report any significant changes.

A patient with type 2 diabetes mellitus is experiencing persistent blurred vision and burning sensation in his feet despite recent modifications to his diabetes management plan. Which of the following interventions would be most appropriate to address these symptoms and improve glycemic control?

B) Initiate therapy with a GLP-1 receptor agonist.

A) Increase the dose of the current antihypertensive medication.

B) Initiate therapy with a GLP-1 receptor agonist.

C) Recommend a daily aspirin regimen to improve circulation.

D) Advise the patient to decrease carbohydrate intake significantly.

A patient with type 2 diabetes mellitus has reported improved energy levels and reduced dizziness after adjustments to his diabetes management plan. However, he continues to experience blurred vision and a burning sensation in his feet. His blood pressure has improved, but fasting blood glucose remains elevated. What is the most appropriate nursing intervention to address his current symptoms and improve his overall management plan?

B) Educate the patient on the potential benefits of adding a GLP-1 receptor agonist to his treatment plan.

A) Encourage the patient to increase his antihypertensive medication dosage to further reduce blood pressure.

B) Educate the patient on the potential benefits of adding a GLP-1 receptor agonist to his treatment plan.

C) Advise the patient to reduce his carbohydrate intake to quickly lower blood glucose levels.

D) Suggest the patient reduce physical activity to avoid exacerbating foot pain.

A patient with type 2 diabetes on a GLP-1 receptor agonist presents with worsening blurred vision and burning sensation in the feet. Which nursing intervention is most appropriate to address these concerns?

A) Educate the patient about the importance of blood glucose monitoring and foot care.

B) Recommend reducing the dose of GLP-1 receptor agonist to alleviate symptoms.

C) Suggest the patient sees a podiatrist for routine foot care to prevent complications.

D) Instruct the patient to increase protein intake to support nerve health.

A patient with type 2 diabetes mellitus has been experiencing worsening blurred vision and a burning sensation in the feet. His recent follow-up showed an improvement in fasting blood glucose levels but revealed signs of diabetic retinopathy and peripheral neuropathy. Which nursing intervention should be prioritized to address the progression of these complications?

A) Encourage the patient to maintain tight glycemic control through medication adherence and lifestyle modifications.

B) Advise the patient to reduce sodium intake to help manage blood pressure levels.

C) Suggest the patient takes over-the-counter supplements to improve nerve function.

D) Recommend the patient undergo immediate laser therapy to prevent further vision loss.

A patient with type 2 diabetes returns for a follow-up visit with a new finding of microalbuminuria. Which of the following interventions should the nurse prioritize to address this complication?

C) Discuss the initiation of an ACE inhibitor or ARB with the healthcare provider

A) Increase the dosage of the patient's current antihypertensive medication

B) Recommend an immediate ophthalmology referral for retinopathy evaluation

C) Discuss the initiation of an ACE inhibitor or ARB with the healthcare provider

D) Encourage the patient to increase physical activity to enhance weight loss

A patient with type 2 diabetes presents with microalbuminuria and reports worsening vision and neuropathic symptoms despite adherence to lifestyle modifications. Which nursing intervention is a priority to address the risk of nephropathy progression?

B) Educate the patient on the importance of consistent blood pressure monitoring and control.

A) Encourage the patient to increase fluid intake to flush the kidneys.

B) Educate the patient on the importance of consistent blood pressure monitoring and control.

C) Recommend a high-protein diet to support kidney function.

D) Advise the patient to limit physical activity to prevent further kidney damage.

A patient with type 2 diabetes is experiencing intensified burning and tingling sensations in his feet, now with occasional numbness, despite improved glycemic control. Which nursing intervention is most appropriate to address the progression of his peripheral neuropathy?

C) Initiate education on the use of gabapentin for managing neuropathic pain.

A) Increase the dose of his current antihypertensive medication.

B) Encourage more frequent blood glucose monitoring to maintain tighter control.

C) Initiate education on the use of gabapentin for managing neuropathic pain.

D) Advise the patient to increase physical activity to improve circulation.

A 58-year-old male patient with a history of type 2 diabetes and hypertension presents with worsening peripheral neuropathy and persistent microalbuminuria, despite recent lifestyle changes and medication adjustments. Which of the following nursing interventions is most appropriate to address his current symptoms and prevent further complications?

A) Educate the patient on the importance of glycemic control and schedule regular foot inspections.

B) Increase the dosage of antihypertensive medication to further lower blood pressure.

C) Recommend the patient to stop the ACE inhibitor due to stable serum creatinine levels.

D) Suggest high-protein dietary modifications to improve renal function.

diabetes mellitus - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency or resistance leads to impaired glucose uptake by cells, causing elevated blood glucose levels. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells results in insulin deficiency. In Type 2 diabetes, cells become resistant to insulin, often due to obesity and sedentary lifestyle.

• Secondary mechanism: Hyperglycemia triggers the release of inflammatory cytokines and increases oxidative stress, damaging blood vessels. This contributes to chronic complications like cardiovascular disease, neuropathy, and retinopathy.

• Key complication: Persistent high blood glucose levels lead to microvascular and macrovascular complications. Microvascular damage affects eyes, kidneys, and nerves, while macrovascular damage increases the risk of heart attack and stroke. Managing blood sugar levels is crucial to prevent these complications.

Patient Profile

Demographics:

55-year-old male, construction worker

History:

• Key past medical history: Diagnosed with type 2 diabetes mellitus 8 years ago, hypertension for 5 years, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 40 mg once daily, low-dose aspirin 81 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and occasional blurred vision

• Key symptoms: Polyuria, polydipsia, numbness in feet, occasional dizziness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, blood glucose 180 mg/dL fasting

Section 1

The patient returned for a follow-up visit two weeks after his initial presentation, reporting persistent fatigue and worsening blurred vision. He also mentioned experiencing more frequent episodes of dizziness and noted that the numbness in his feet had progressed to tingling and a burning sensation. During the assessment, his blood pressure was recorded at an elevated 155/98 mmHg. A repeat fasting blood glucose level showed persistently high levels at 190 mg/dL, suggesting inadequate glycemic control despite medication adherence. A comprehensive metabolic panel revealed a hemoglobin A1c of 8.5%, indicating chronic hyperglycemia.

Upon further evaluation, a monofilament test and vibration perception test confirmed decreased sensation in the feet, suggesting diabetic neuropathy. Additionally, a dilated retinal exam conducted by an ophthalmologist revealed signs of non-proliferative diabetic retinopathy, characterized by microaneurysms and retinal hemorrhages. Given his occupation, the implications of these findings could affect his ability to perform his duties safely, especially with the noted visual impairments and peripheral neuropathy.

The clinical team discussed the importance of optimizing his diabetes management, considering potential adjustments to his metformin regimen, and the inclusion of additional glucose-lowering agents. The patient was counseled on lifestyle modifications, emphasizing dietary changes and increased physical activity to aid in weight management and improve insulin sensitivity. A referral to a diabetes educator and a podiatrist was made to address foot care and prevent further complications. The team also planned to initiate antihypertensive therapy intensification to better control his blood pressure and reduce cardiovascular risks. As the patient left the clinic, the focus was on closely monitoring for any new symptoms that could indicate further progression of diabetic complications.

Section 2

Two weeks after the adjustments to his diabetes management plan, the patient returned for another follow-up visit. He reported a slight improvement in his energy levels and a reduction in episodes of dizziness, but he still experienced significant issues with blurred vision and the burning sensation in his feet. The clinical team noted that his blood pressure had improved to 148/90 mmHg, reflecting some progress from the increased antihypertensive therapy. However, his fasting blood glucose remained elevated at 180 mg/dL, indicating that additional measures were needed to achieve better glycemic control.

A repeat hemoglobin A1c test showed a marginal improvement to 8.2%, but this was still above the target level, suggesting that the current interventions were insufficient in fully addressing his chronic hyperglycemia. The patient expressed concerns about his ability to continue his job effectively, given the persistent visual impairments and sensory issues affecting his feet. These concerns prompted the team to consider further modifications to his treatment regimen. They discussed the potential addition of a GLP-1 receptor agonist to enhance glucose control and support weight loss, which could contribute to better overall diabetic management.

Given the patient's current status, the team emphasized the need for continuous monitoring and frequent follow-up appointments. They reinforced the importance of lifestyle modifications, particularly focusing on maintaining a consistent exercise routine and adhering to dietary recommendations. A plan was made to revisit the patient's progress in another month to reassess his response to the new therapeutic strategies and to monitor for any signs of emerging complications, such as worsening retinopathy or advancing neuropathy. The patient left the clinic with a renewed sense of commitment to his health, understanding the importance of his active participation in managing his diabetes.

Section 3

One month later, the patient returned for his follow-up appointment with signs of both progress and new concerns. He reported that the addition of the GLP-1 receptor agonist had helped reduce his fasting blood glucose levels, which were now averaging around 140 mg/dL. His hemoglobin A1c had decreased to 7.8%, reflecting an improvement, though still above the desired target. Despite these gains, he continued to experience significant blurred vision, which had now worsened, and an increase in the burning sensation in his feet. During the physical assessment, the clinical team noted diminished vibratory sensation and decreased monofilament testing results on his feet, indicating a progression of peripheral neuropathy.

The blood pressure readings showed further improvement, now at 140/88 mmHg, suggesting successful management with the antihypertensive regimen. However, the patient's weight had slightly increased by 3 pounds, potentially undermining some of the metabolic improvements. Fundoscopic examination revealed changes consistent with diabetic retinopathy, including microaneurysms and cotton wool spots, necessitating a referral to an ophthalmologist for further evaluation and management.

The team discussed these findings with the patient, emphasizing the importance of tight glycemic and blood pressure control to slow the progression of retinopathy and neuropathy. The patient was advised to increase his daily physical activity and adjust his dietary intake to address the weight gain. They reiterated the need for regular eye exams and discussed the possibility of further interventions, such as laser therapy, depending on the ophthalmologist's assessment. With these new developments, the patient was encouraged to remain engaged in his care plan and to report any new or worsening symptoms promptly. The plan was to follow up again in six weeks to evaluate the impact of these adjustments and to continue monitoring for any additional complications.

Section 4

Six weeks later, the patient returned for his scheduled follow-up visit. During the initial assessment, the clinical team noted several changes in his clinical status. The patient reported adherence to the recommended lifestyle modifications, including increased physical activity and dietary adjustments, which had resulted in a modest weight reduction of 4 pounds. His blood glucose monitoring logs indicated improved glycemic control, with fasting blood glucose levels now averaging 130 mg/dL. However, he expressed persistent concerns about his vision, noting that the blurriness had slightly worsened, affecting his ability to perform daily tasks comfortably. Additionally, he continued to experience burning and tingling in his feet, despite these lifestyle changes.

The laboratory results revealed a further decrease in hemoglobin A1c to 7.5%, indicating progress but still not reaching the optimal target. His blood pressure was stable at 138/86 mmHg, demonstrating effective management through his current antihypertensive regimen. However, a urinalysis revealed microalbuminuria, suggesting early nephropathy development, a common complication in diabetes patients. The team discussed the significance of this finding with the patient, highlighting the importance of kidney function monitoring and potential adjustments to his treatment plan to protect renal health.

Given these developments, the clinical team emphasized the necessity of a comprehensive approach to managing his diabetes and its complications. They discussed the potential need for additional medication to address the microalbuminuria and considered the introduction of an ACE inhibitor or ARB to provide renal protection. The patient was advised to continue his current regimen, maintain regular physical activity, and adhere to dietary recommendations. The team reinforced the importance of attending the ophthalmologist appointment to assess the progression of retinopathy and explore potential interventions such as laser therapy. A follow-up appointment was scheduled in another six weeks to monitor his response to these adjustments and evaluate any further developments in his condition.

Section 5

Six weeks later, the patient returned for his follow-up appointment, eager to assess the outcomes of the recent interventions. During the initial assessment, the clinical team observed that the patient had lost an additional 3 pounds, bringing his total weight loss to 7 pounds since adopting lifestyle changes. His blood pressure was slightly improved at 134/84 mmHg, indicating a positive response to the antihypertensive regimen and lifestyle modifications. However, the patient reported that the burning and tingling sensations in his feet had intensified, now accompanied by occasional numbness, suggesting a progression in peripheral neuropathy. His vision issues persisted, with increased difficulty reading small print and driving at night.

The latest laboratory results showed a further reduction in hemoglobin A1c to 7.2%, reflecting significant progress in glycemic control. Yet, the urinalysis indicated persistent microalbuminuria at 40 mg/g, underscoring the need for continued attention to renal health. The patient had begun an ACE inhibitor regimen since the last visit, and the team was keen to evaluate its impact on his renal function. A serum creatinine test returned with a stable value of 1.1 mg/dL, indicating no immediate adverse effects from the medication, but reinforcing the need for regular monitoring.

The clinical team discussed the new findings with the patient, highlighting the importance of addressing the neuropathic symptoms. They considered the introduction of a medication specifically targeting neuropathic pain, such as gabapentin. Additionally, plans for an immediate ophthalmologist referral were emphasized, given the concerning progression of retinopathy symptoms. The team reiterated the importance of maintaining lifestyle changes and medication adherence, scheduling another follow-up in eight weeks to closely monitor the neuropathy and reassess the effectiveness of the ACE inhibitor on renal protection. This stepwise approach aimed to manage the current complications while minimizing the risk of further progression.